Signs and Symptoms, Digestive News

Signs and Symptoms, Digestive	Welcome, Profile Billing Logout

«1 2...16 17 18 19 202122 23 24 25 26...32 33 »

|||||||||| Trial completion: The Efficacy of P6 Acupressure in Reducing Postoperative Nausea and Vomiting in Patients Undergoing Craniotomy (clinicaltrials.gov) - Sep 16, 2013
P2/3, N=80, Completed, Sponsor: Umeå University
Enrolling by invitation --> Completed

|||||||||| Enrollment open: Does Body Position Influence Pressure Recording by High-resolution Manometry ? (clinicaltrials.gov) - Sep 15, 2013
P=N/A, N=40, Recruiting, Sponsor: Assistance Publique Hopitaux De Marseille
Enrolling by invitation --> Completed Not yet recruiting --> Recruiting

|||||||||| New P1/2 trial: Effect of a Lacidofil® STRONG in Healthy Adults Taking Antibiotic Treatment (clinicaltrials.gov) - Sep 11, 2013
P1/2, N=160, Active, not recruiting, Sponsor: KGK Synergize Inc.

|||||||||| Biomarker, Enrollment open: Safety and Effect of L. Reuteri on Biomarkers of Inflammation in Healthy Infants With Colic (clinicaltrials.gov) - Sep 11, 2013
P1, N=70, Recruiting, Sponsor: The University of Texas Health Science Center, Houston
Not yet recruiting --> Recruiting Not yet recruiting --> Recruiting

|||||||||| New P2 trial: Efficacy and Safety of a Probiotic Product in Children With Antibiotic-associated Gastrointestinal Disorders. (clinicaltrials.gov) - Sep 10, 2013
P2, N=400, Recruiting, Sponsor: Probi AB

||||||||||  mizagliflozin (VGX-3235) / Vogenx
New P2 trial:  A Single-blind, Dose-titration Study of KWA-0711 in Patients With Chronic Constipation (clinicaltrials.gov) -  Sep 8, 2013
P2, N=0, Recruiting,  Sponsor: Kissei Pharmaceutical Co., Ltd.

||||||||||  mizagliflozin (VGX-3235) / Vogenx
New P2 trial:  A Single-blind, Dose-tapering Study of KWA-0711 in Patients With Chronic Constipation (clinicaltrials.gov) -  Sep 6, 2013
P2, N=0, Recruiting,  Sponsor: Kissei Pharmaceutical Co., Ltd.

|||||||||| Trial completion: AADreuter: Probiotic Lactobacillus Reuteri to Prevent Antibiotic-associated Diarrhea and Clostridium Difficile-related Infections in Hospitalized Children (clinicaltrials.gov) - Sep 6, 2013
P3, N=100, Completed, Sponsor: St Marina University Hospital, Varna, Bulgaria
Not yet recruiting --> Recruiting Recruiting --> Completed

||||||||||  Sancuso (granisetron) / Solasia
New P3 trial:  A Randomized Controlled Trial of SP-01 (Granisetron Transdermal Delivery System) in Chemotherapy-induced Nausea and Vomiting (clinicaltrials.gov) -  Sep 5, 2013
P3, N=313, Completed,  Sponsor: Solasia Pharma K.K.

||||||||||  aprepitant oral / Generic mfg.
Trial completion:  A Study of the Safety and Efficacy of Aprepitant for the Prevention of Chemotherapy-Induced Nausea and Vomiting (CINV) in Pediatric Participants (MK-0869-208) (clinicaltrials.gov) -  Sep 3, 2013
P3, N=307, Completed,  Sponsor: Merck Sharp & Dohme Corp.
Recruiting --> Completed Active, not recruiting --> Completed

|||||||||| New P2 trial: Treatment of Anxiety and Anorexia Nervosa in Adolescents (clinicaltrials.gov) - Aug 29, 2013
P2, N=40, Recruiting, Sponsor: Nationwide Children's Hospital

|||||||||| Enrollment change: WASHB-Kenya: WASH Benefits Kenya (clinicaltrials.gov) - Aug 28, 2013
P=N/A, N=8000, Recruiting, Sponsor: Innovations for Poverty Action
Active, not recruiting --> Completed N=11250 --> 8000

|||||||||| Trial completion: Effect of Perilla Extract on Improvement on Gastrointestinal Discomfort (clinicaltrials.gov) - Aug 28, 2013
P=N/A, N=47, Completed, Sponsor: Amino Up Chemicals Co., Ltd.
N=11250 --> 8000 Not yet recruiting --> Completed

|||||||||| Enrollment closed: A Colonic Tube to Improve Bowel Function in Spinal Cord Injury (clinicaltrials.gov) - Aug 26, 2013
P=N/A, N=25, Active, not recruiting, Sponsor: Department of Veterans Affairs
Not yet recruiting --> Completed Recruiting --> Active, not recruiting

|||||||||| Enrollment open: Effect of TU-100 in Patients With Irritable Bowel Syndrome (IBS) (clinicaltrials.gov) - Aug 26, 2013
P1/2, N=40, Recruiting, Sponsor: Tsumura USA
Recruiting --> Active, not recruiting Not yet recruiting --> Recruiting

|||||||||| Trial completion, HEOR, Cost effectiveness: Acupressure Wristbands or Standard Care in Controlling Nausea Caused by Chemotherapy (clinicaltrials.gov) - Aug 22, 2013
P3, N=699, Completed, Sponsor: University of Manchester
Not yet recruiting --> Recruiting Recruiting --> Completed

|||||||||| Enrollment open: Longitudinal Study of Patients With Opioid-Induced Constipation (clinicaltrials.gov) - Aug 21, 2013
P=N/A, N=900, Recruiting, Sponsor: AstraZeneca
Recruiting --> Completed Not yet recruiting --> Recruiting

|||||||||| Enrollment closed: Emergency Department Ultrasound in Renal Colic (clinicaltrials.gov) - Aug 21, 2013
P=N/A, N=400, Active, not recruiting, Sponsor: Queen's University
Not yet recruiting --> Recruiting Recruiting --> Active, not recruiting

||||||||||  famotidine / Generic mfg.
Trial completion:  Placebo Controlled Phase IV Study to Compare the Efficacy and Safety of a Single Dose of Oral Talcid, a Single Dose of Oral Famotidine and a Single Dose of Placebo in Patients With Acute Heartburn Episodes (clinicaltrials.gov) -  Aug 21, 2013
P4, N=477, Completed,  Sponsor: Bayer
Recruiting --> Active, not recruiting Not yet recruiting --> Completed

|||||||||| Clinical: HMO-VOL: The Effects Of HMO On The Faecal Microbiota And On Gastrointestinal Symptoms In Healthy Volunteers (clinicaltrials.gov) - Aug 21, 2013
P=N/A, N=100, Not yet recruiting, Sponsor: Glycom A/S

||||||||||  aprepitant oral / Generic mfg.
Enrollment change:  A Study to Evaluate the Safety and Efficacy of Aprepitant (MK0869) for Chemotherapy-Induced Nausea and Vomiting in Pediatric Patients (clinicaltrials.gov) -  Aug 20, 2013
P=N/A, N=20, Completed,  Sponsor: West Virginia University Healthcare
Not yet recruiting --> Completed N=40 --> 20

||||||||||  aprepitant oral / Generic mfg.
Trial completion:  A Study to Evaluate the Safety and Efficacy of Aprepitant (MK0869) for Chemotherapy-Induced Nausea and Vomiting in Pediatric Patients (clinicaltrials.gov) -  Aug 20, 2013
P=N/A, N=20, Completed,  Sponsor: West Virginia University Healthcare
N=40 --> 20 Recruiting --> Completed

|||||||||| New P4 trial: PROBAGE: Effects of Probiotics and/or Prebiotics on the Duration of Diarrhea and Hospitalization in Children (clinicaltrials.gov) - Aug 20, 2013
P4, N=1280, Recruiting, Sponsor: Eskisehir Osmangazi University

||||||||||  famotidine / Generic mfg.
New P4 trial:  Placebo Controlled Phase IV Study to Compare the Efficacy and Safety of a Single Dose of Oral Talcid, a Single Dose of Oral Famotidine and a Single Dose of Placebo in Patients With Acute Heartburn Episodes (clinicaltrials.gov) -  Aug 19, 2013
P4, N=477, Completed,  Sponsor: Bayer

|||||||||| Enrollment open: A Comparison of Methylphenidate and Cognitive Behavioural Therapy for the Treatment of Binge Eating Disorder (clinicaltrials.gov) - Aug 19, 2013
P2, N=56, Recruiting, Sponsor: Centre for Addiction and Mental Health
Recruiting --> Completed Not yet recruiting --> Recruiting

|||||||||| Enrollment open: Guided Self-help for Binge Eating (clinicaltrials.gov) - Aug 19, 2013
P=N/A, N=102, Recruiting, Sponsor: Oxford Health NHS Foundation Trust
Not yet recruiting --> Recruiting Not yet recruiting --> Recruiting

|||||||||| Enrollment open: PROBAGE: Effects of Probiotics and/or Prebiotics on the Duration of Diarrhea and Hospitalization in Children (clinicaltrials.gov) - Aug 18, 2013
P4, N=1280, Recruiting, Sponsor: Eskisehir Osmangazi University
Not yet recruiting --> Recruiting Not yet recruiting --> Recruiting

||||||||||  Linzess (linaclotide) / Astellas, Ironwood Pharma, AbbVie
Enrollment open:  A Phase 3, International, Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group Efficacy and Safety Trial of Linaclotide Administered Orally for 12 Weeks to Patients With Irritable Bowel Syndrome With Constipation (IBS-C) (clinicaltrials.gov) -  Aug 18, 2013
P3, N=800, Recruiting,  Sponsor: AstraZeneca
Not yet recruiting --> Recruiting Not yet recruiting --> Recruiting

|||||||||| Trial initiation date: A Study to Demonstrate the Efficacy and Safety of Motilitone® (clinicaltrials.gov) - Aug 12, 2013
P4, N=387, Recruiting, Sponsor: Dong-A Pharmaceutical Co., Ltd.
Not yet recruiting --> Recruiting Initiation date: Jan 2012 --> Aug 2012

|||||||||| Enrollment change: A Study to Demonstrate the Efficacy and Safety of Motilitone® (clinicaltrials.gov) - Aug 12, 2013
P4, N=387, Recruiting, Sponsor: Dong-A Pharmaceutical Co., Ltd.
Initiation date: Jan 2012 --> Aug 2012 N=31 --> 387

|||||||||| Enrollment open: A Study to Demonstrate the Efficacy and Safety of Motilitone® (clinicaltrials.gov) - Aug 12, 2013
P4, N=387, Recruiting, Sponsor: Dong-A Pharmaceutical Co., Ltd.
N=31 --> 387 Completed --> Recruiting

|||||||||| Enrollment change: ASFT: Acceptance-Based Separated Family Treatment for Adolescent Anorexia Nervosa (clinicaltrials.gov) - Aug 11, 2013
P=N/A, N=75, Completed, Sponsor: Duke University
Completed --> Recruiting N=22 --> 75

|||||||||| New P2 trial: A Comparison of Methylphenidate and Cognitive Behavioural Therapy for the Treatment of Binge Eating Disorder (clinicaltrials.gov) - Aug 11, 2013
P2, N=56, Recruiting, Sponsor: Centre for Addiction and Mental Health

|||||||||| Trial completion: ASFT: Acceptance-Based Separated Family Treatment for Adolescent Anorexia Nervosa (clinicaltrials.gov) - Aug 11, 2013
P=N/A, N=75, Completed, Sponsor: Duke University
N=22 --> 75 Recruiting --> Completed

|||||||||| Trial completion: Economics of Diarrhoea in Intensive Care Unit (clinicaltrials.gov) - Aug 10, 2013
P=N/A, N=305, Completed, Sponsor: University Hospital, Geneva
Recruiting --> Completed Not yet recruiting --> Completed

|||||||||| Trial completion: Effect of TU-100 in Patients With Functional Constipation (clinicaltrials.gov) - Aug 8, 2013
P2, N=50, Completed, Sponsor: Tsumura USA
Not yet recruiting --> Completed Active, not recruiting --> Completed

||||||||||  ondansetron intravenous / Generic mfg., aprepitant oral / Generic mfg.
Trial withdrawal, Surgery:  Aprepitant PO vs Ondansetron IV for Prevention of Postoperative Nausea and Vomiting (clinicaltrials.gov) -  Aug 7, 2013
P=N/A, N=0, Withdrawn,  Sponsor: North Shore Long Island Jewish Health System
Active, not recruiting --> Completed Terminated --> Withdrawn

||||||||||  ondansetron intravenous / Generic mfg., aprepitant oral / Generic mfg.
Enrollment change, Surgery:  Aprepitant PO vs Ondansetron IV for Prevention of Postoperative Nausea and Vomiting (clinicaltrials.gov) -  Aug 7, 2013
P=N/A, N=0, Withdrawn,  Sponsor: North Shore Long Island Jewish Health System
Terminated --> Withdrawn N=19 --> 0

|||||||||| Trial completion: The Effect of Milk Powder With Fiber and Probiotics on Digestive Habits and General Health Well-being of Selected Filipino Mothers. (clinicaltrials.gov) - Aug 5, 2013
P=N/A, N=72, Completed, Sponsor: Fonterra Research Centre
N=19 --> 0 Active, not recruiting --> Completed

||||||||||  docetaxel / Generic mfg.
Trial completion:  CRUK/07/013: Symptom Control With or Without Docetaxel in Treating Patients With Relapsed Esophageal Cancer or Stomach Cancer (clinicaltrials.gov) -  Aug 5, 2013
P3, N=320, Completed,  Sponsor: Cambridge University Hospitals NHS Foundation Trust
Active, not recruiting --> Completed Recruiting --> Completed

||||||||||  dexamethasone / Generic mfg., ondansetron / Generic mfg.
Enrollment closed:  VPOP2: Postoperative Vomiting in Children: Comparison Tri - Versus bi -Prophylaxis (clinicaltrials.gov) -  Aug 1, 2013
P=N/A, N=322, Active, not recruiting,  Sponsor: Assistance Publique - Hôpitaux de Paris
Recruiting --> Completed Recruiting --> Active, not recruiting

|||||||||| Clinical: Response to Supplement and Placebo in GERD (clinicaltrials.gov) - Jul 31, 2013
P=N/A, N=24, Recruiting, Sponsor: Beth Israel Deaconess Medical Center

||||||||||  prochlorperazine maleate / Generic mfg.
Enrollment change:  Ondansetron vs Prochlorperazine for Nausea and Vomiting in the Emergency Department (clinicaltrials.gov) -  Jul 30, 2013
P2, N=64, Completed,  Sponsor: Emory University
Recruiting --> Active, not recruiting N=150 --> 64

||||||||||  Amitiza (lubiprostone) / Takeda, Mallinckrodt
Trial completion:  Lubiprostone and Mucus Secretion in Patients With Chronic Constipation (clinicaltrials.gov) -  Jul 30, 2013
P2/3, N=40, Completed,  Sponsor: Texas Tech University Health Sciences Center
N=150 --> 64 Recruiting --> Completed

||||||||||  prochlorperazine maleate / Generic mfg.
Trial completion:  Ondansetron vs Prochlorperazine for Nausea and Vomiting in the Emergency Department (clinicaltrials.gov) -  Jul 30, 2013
P2, N=64, Completed,  Sponsor: Emory University
Recruiting --> Completed Recruiting --> Completed

|||||||||| New P2 trial, Surgery: Different Fluidic Strategy in Patients With Acute Abdomen : The Sure Volume (clinicaltrials.gov) - Jul 28, 2013
P2, N=99, Completed, Sponsor: Azienda Ospedaliera - Universitaria di Modena

|||||||||| Trial completion: A Trial of 0.025 Wire Guided Cannulation Versus Current Practice 0.035 Wire Guided Cannulation (clinicaltrials.gov) - Jul 28, 2013
P4, N=184, Completed, Sponsor: Chinese University of Hong Kong
Recruiting --> Completed Active, not recruiting --> Completed

||||||||||  morphine sulphate / Generic mfg.
New P2 trial:  Comparing the Analgesic Effect of Intravenous Acetaminophen and Morphine on Patients With Renal Colic Pain Reffering to the Emergency Department: A Randomized Controlled Trial (clinicaltrials.gov) -  Jul 22, 2013
P2, N=124, Completed,  Sponsor: Seyed Mehdi Pourafzali

||||||||||  Sancuso (granisetron) / Solasia
Trial completion:  Phase 4 Trial to Evaluate the Efficacy and Safety of Sancuso Patch in Chemotherapy-induced Nausea and Vomiting Associated With the Administration of Highly Emetogenic Chemotherapy (HEC) (clinicaltrials.gov) -  Jul 22, 2013
P4, N=389, Completed,  Sponsor: LG Life Sciences
Active, not recruiting --> Completed Recruiting --> Completed

|||||||||| Trial completion: Effect of Yoga in Reducing Chemotherapy Induced Nausea and Vomiting (clinicaltrials.gov) - Jul 22, 2013
P2, N=120, Completed, Sponsor: Bharath Charitable Cancer Hospital and Institute
Recruiting --> Completed Recruiting --> Completed



	Diseases Companies Products Productz Mechanisms of Action Sites